Assessing the impact of MRI based diagnostics on pre-treatment disease classification and prognostic model performance in men diagnosed with new prostate cancer from an unscreened population

INTRODUCTION: Pre-treatment risk and prognostic groups are the cornerstone for deciding management in non-metastatic prostate cancer. All however, were developed in the pre-MRI era. Here we compared categorisation of cancers using either only clinical parameters or with MRI enhanced information in m...

Descripción completa

Detalles Bibliográficos
Autores principales: Lophatananon, Artitaya, Byrne, Matthew H. V., Barrett, Tristan, Warren, Anne, Muir, Kenneth, Dokubo, Ibifuro, Georgiades, Fanos, Sheba, Mostafa, Bibby, Lisa, Gnanapragasam, Vincent J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367076/
https://www.ncbi.nlm.nih.gov/pubmed/35953766
http://dx.doi.org/10.1186/s12885-022-09955-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367076/
https://www.ncbi.nlm.nih.gov/pubmed/35953766
http://dx.doi.org/10.1186/s12885-022-09955-w

Ejemplares similares